269 related articles for article (PubMed ID: 27562355)
1. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
[TBL] [Abstract][Full Text] [Related]
2. Magnitude of Missed Esophageal Adenocarcinoma After Barrett's Esophagus Diagnosis: A Systematic Review and Meta-analysis.
Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
Gastroenterology; 2016 Mar; 150(3):599-607.e7; quiz e14-5. PubMed ID: 26619962
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
[TBL] [Abstract][Full Text] [Related]
4. Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.
Hamade N; Kamboj AK; Krishnamoorthi R; Singh S; Hassett LC; Katzka DA; Kahi CJ; Fatima H; Iyer PG
Aliment Pharmacol Ther; 2021 Sep; 54(5):546-559. PubMed ID: 34275161
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients.
Tan MC; Mansour N; White DL; Sisson A; El-Serag HB; Thrift AP
Aliment Pharmacol Ther; 2020 Jul; 52(1):20-36. PubMed ID: 32452599
[TBL] [Abstract][Full Text] [Related]
6. Increased detection rates of Barrett's oesophagus without rise in incidence of oesophageal adenocarcinoma.
Hurschler D; Borovicka J; Neuweiler J; Oehlschlegel C; Sagmeister M; Meyenberger C; Schmid U
Swiss Med Wkly; 2003 Sep; 133(37-38):507-14. PubMed ID: 14652799
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Barrett's adenocarcinoma in an Italian population: an endoscopic surveillance programme. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE).
Ferraris R; Bonelli L; Conio M; Fracchia M; Lapertosa G; Aste H
Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):881-5. PubMed ID: 9355787
[TBL] [Abstract][Full Text] [Related]
8. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
Januszewicz W; Kaminski MF; Wieszczy P; Wronska E; Bielasik A; Wojciechowska U; Didkowska J; Orlowska J; Regula J
Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 27377059
[TBL] [Abstract][Full Text] [Related]
10. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis.
Caygill CP; Reed PI; Johnston BJ; Hill MJ; Ali MH; Levi S
Eur J Gastroenterol Hepatol; 1999 Dec; 11(12):1355-8. PubMed ID: 10654794
[TBL] [Abstract][Full Text] [Related]
11. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota.
Conio M; Cameron AJ; Romero Y; Branch CD; Schleck CD; Burgart LJ; Zinsmeister AR; Melton LJ; Locke GR
Gut; 2001 Mar; 48(3):304-9. PubMed ID: 11171817
[TBL] [Abstract][Full Text] [Related]
12. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
13. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
15. Yield of Repeat Endoscopy in Barrett's Esophagus with No Dysplasia and Low-Grade Dysplasia: A Population-Based Study.
Visrodia K; Iyer PG; Schleck CD; Zinsmeister AR; Katzka DA
Dig Dis Sci; 2016 Jan; 61(1):158-67. PubMed ID: 25956705
[TBL] [Abstract][Full Text] [Related]
16. Dysplasia and risk of further neoplastic progression in a regional Veterans Administration Barrett's cohort.
Dulai GS; Shekelle PG; Jensen DM; Spiegel BM; Chen J; Oh D; Kahn KL
Am J Gastroenterol; 2005 Apr; 100(4):775-83. PubMed ID: 15784018
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
[TBL] [Abstract][Full Text] [Related]
18. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
19. External validation of a model to determine risk of progression of Barrett's oesophagus to neoplasia.
Kunzmann AT; Thrift AP; Johnston BT; McManus DT; Gavin AT; Turkington RC; Coleman HG
Aliment Pharmacol Ther; 2019 May; 49(10):1274-1281. PubMed ID: 30950101
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
Wolfsen HC; Hemminger LL; Wallace MB; Devault KR
Aliment Pharmacol Ther; 2004 Nov; 20(10):1125-31. PubMed ID: 15569115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]